A Global Comparison of the Human and T. brucei Degradomes Gives Insights about Possible Parasite Drug Targets

• Susan T. Mashiyama,

  Affiliations Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biomedical Research (QB3), University of California San Francisco, San Francisco, California, United States of America, Center for Discovery and Innovation in Parasitic Diseases, and Department of Pathology, QB3, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Kyriacos Koupparis,

  Affiliation Center for Discovery and Innovation in Parasitic Diseases, and Department of Pathology, QB3, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Conor R. Caffrey,

  Affiliation Center for Discovery and Innovation in Parasitic Diseases, and Department of Pathology, QB3, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• James H. McKerrow ,

  * E-mail: jmck@cgl.ucsf.edu (JHM); babbitt@cgl.ucsf.edu (PCB)

  Affiliation Center for Discovery and Innovation in Parasitic Diseases, and Department of Pathology, QB3, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Patricia C. Babbitt

  * E-mail: jmck@cgl.ucsf.edu (JHM); babbitt@cgl.ucsf.edu (PCB)

  Affiliation Department of Bioengineering and Therapeutic Sciences, California Institute for Quantitative Biomedical Research (QB3), University of California San Francisco, San Francisco, California, United States of America

  ⨯